10. Aitken, R.J., Bromfield, E.G., & Gibb, Z. (2022). Oxidative Stress and Productive Function: The impact of oxidative stress on reproduction: a focus on gametogenesis and fertilization. Reproduction (Cambridge, England), 164(6), F79–F94. https://doi.org/10.1530/REP-22-0126.

11. Akbari, M., & Hosseini, Z.S. (2020). A Meta-Analysis of Comparing the Efficacy of the Third Wave of Behavior Therapies on Depression in Iran: Comparing Acceptance and Commitment Therapy, Mindfulness-Based Therapy and Metacognitive Therapy (2001-2017). Clinical Psychology and Personality, 17(1), 175-189. (In Persian) doi: 10.22070/cpap.2020.2895.

12. Amini, F., Jafariroshan, M., & Leilabadi, L. (2024). Comparing the effectiveness of cognitive behavioral skills training, mindfulness skills, and cognitive behavioral self-help skills based on virtual space on depression and social health of women with depression. Journal of Psychological Science. 22(131):39-60. (In Persian) doi:10.52547/JPS.22.131.2207

13. Andriolo, I.L., Longo, B., de Melo, D.M., de Souza, M.M., Prediger, R.D., & da Silva, L. M. (2024). Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications. CNS & Neurological Disorders Drug Targets, 23(11), 1371–1391. https://doi.org/10.2174/0118715273289138240306050532

14. Armstrong, R. (2020). What causes neurodegenerative disease?. Folia Neuropathologica, 58(2), 93–112. https://doi.org/10.5114/fn.2020.96707.

15. Aza, A., Gómez-Vela, M., Badia, M., Begoña Orgaz, M., González-Ortega, E., Vicario-Molina, I., & Montes-López, E. (2022). Listening to families with a person with neurodegenerative disease talk about their quality of life: integrating quantitative and qualitative approaches. Health and Quality of Life Outcomes, 20(1), 76. https://doi.org/10.1186/s12955-022-01977-z.

16. Bell, G., Baou, C.E., Saunders, R., Buckman, J.E.J., Charlesworth, G., Richards, M., Brown, B., Nurock, S., Michael, S., Ware, P., Aguirre, E., Rio, M., Cooper, C., Pilling, S., John, A., & Stott, J. (2022). Effectiveness of primary care psychological therapy services for the treatment of depression and anxiety in people living with dementia: Evidence from national healthcare records in England. E. Clinical Medicine, 52, 101692. https://doi.org/10.1016/j.eclinm.2022.101692.

17. Bruijniks, S.E., Hollon, S.D., Lemmens, L.J. M., Peeters, F.L., Arntz, A., Cuijpers, P., Huibers, M.H. (2024). Long-term outcomes of once weekly v. twice weekly sessions of cognitive behavioral therapy and interpersonal psychotherapy for depression. Psychological Medicine, 54(3), 517–526. doi:10.1017/S0033291723002143.

18. Cavaliere, F., & Gülöksüz, S. (2022). Shedding light on the etiology of neurodegenerative diseases and dementia: the exposome paradigm. Npj Mental Health Research, 1(1), 20. https://doi.org/10.1038/s44184-022-00018-3.

19. Ciharova, M., Karyotaki, E., Miguel, C., Walsh, E., de Ponti, N., Amarnath, A., van Ballegooijen, W., Riper, H., Arroll, B., & Cuijpers, P. (2024). Amount and frequency of psychotherapy as predictors of treatment outcome for adult depression: A meta-regression analysis. Journal of Affective Disorders, 359,92–99. https://doi.org/10.1016/j.jad.2024.05.070.

20. Cuijpers, P., Miguel, C., Harrer, M., Plessen, C.Y., Ciharova, M., Ebert, D., & Karyotaki, E. (2023). Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta-analysis including 409 trials with 52,702 patients. World psychiatry: official journal of the World Psychiatric Association (WPA), 22(1),105–115. https://doi.org/10.1002/wps.21069.

21. Davenport, F., Gallacher, J., Kourtzi, Z., Koychev, I., Matthews, P.M., Oxtoby, N. P., Parkes, L.M., Priesemann, V., Rowe, J.B., Smye, S.W., & Zetterberg, H. (2023). Neurodegenerative disease of the brain: a survey of interdisciplinary approaches. Journal of the Royal Society, Interface, 20(198),20220406. https://doi.org/10.1098/rsif.2022.0406.

22. Dejanovic, B., Sheng, M., & Hanson, J.E. (2024). Targeting synapse function and loss for treatment of neurodegenerative diseases. Nature Reviews. Drug Discovery, 23(1),23–42. https://doi.org/10.1038/s41573-023-00823-1.

23. Dobkin, R.D., Menza, M., Allen, L.A., Gara, M.A., Mark, M.H., Tiu, J., Bienfait, K.L., & Friedman, J. (2011). Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. The American Journal of Psychiatry, 168(10),1066–1074. https://doi.org/10.1176/appi.ajp.2011.10111669. Ebrahimi, M., Raiisi, F., Ghahvehchi-Hosseini, F., Jafari, K., & Rahmati, F. (2024). Investigating Depression iteracy in Military Adults of Mashhad. Payesh, 23(3),473-479. (In Persian) Doi: 10.61186/payesh.23.3.473.

24. Firoozikhojastehfar, R., Asgari, K., Kalantari, M., Raisi, F., & shahvari, Z. (2021). Comparison of the effectiveness of cognitive–behavioral therapy and acceptance and commitment therapy on depression symptoms and hypersexual behaviours in patients with sex addiction. Journal of Psychological Science. 20(99),341-352. (In Persian). Doi:20.1001.1.17357462.1400.20.99.1.2.

25. Galante, J., Friedrich, C., Dalgleish, T., Jones, P. B., & White, I.R. (2023). Individual participant data systematic review and meta-analysis of randomized controlled trials assessing adult mindfulness-based program for mental health promotion in non-clinical settings. Nature. Mental Health, 1(7),462–476. https://doi.org/10.1038/s44220-023-00081-5.

26. Galts, C.C., Bettio, L.B., Jewett, D.C., Yang, C. C., Brocardo, P.S., Rodrigues, A. S., Thacker, J.S., & Gil-Mohapel, J. (2019). Depression in neurodegenerative diseases: Common mechanisms and current treatment options. Neuroscience and Biobehavioral Reviews, 102,56–84. https://doi.org/10.1016/j.neubiorev.2019.04.002.

27. Gaskell, C., Simmonds-Buckley, M., Kellett, S., Stockton, C., Somerville, E., Rogerson, E., & Delgadillo, J. (2023). The Effectiveness of Psychological Interventions Delivered in Routine Practice: Systematic Review and Meta-analysis. Administration and Policy in Mental Health, 50(1),43–57. https://doi.org/10.1007/s10488-022-01225-y.

28. Ghodspour, Z., Najafi, M., & Rahimian Boogar, I. (2018). Effectiveness of Mindfulness-Based Cognitive Therapy on Psychological Aspects of Quality of Life, Depression, Anxiety, and Stress Among Patients with Multiple Sclerosis. Journal of Practice in Clinical Psychology, 6(4), 215-222. http://dx.doi.org/10.32598/jpcp.6.4.215

29. Guo, Y., Ma, G., Wang, Y., Lin, T., Hu, Y., & Zang, T. (2024). Causal associations and shared genetic etiology of neurodegenerative diseases with epigenetic aging and human longevity. Aging Cell, 23(11),e14271. https://doi.org/10.1111/acel.14271.

30. Guo, D., Wang, C., & Liu, X. (2024). Association of chronic diseases with depression in the United States, NHANES 2007-2018. Psychology, Health & Medicine, 29(5), 1077–1090. https://doi.org/10.1080/13548506.2023.2277153.

31. Hakim A.M. (2021). A Proposed Hypothesis on Dementia: Inflammation, Small Vessel Disease, and Hypoperfusion Is the Sequence That Links All Harmful Lifestyles to Cognitive Impairment. Frontiers in Aging Neuroscience, 13, 679837. https://doi.org/10.3389/fnagi.2021.679837.

32. Hakim, A. (2022). Perspectives on the complex links between depression and dementia. Frontiers in Aging Neuroscience, 14,821866. https://doi.org/10.3389/fnagi.2022.821866.

33. Hall, S., Parr, B. A., Hussey, S., Anoopkumar-Dukie, S., Arora, D., & Grant, G.D. (2024). The neurodegenerative hypothesis of depression and the influence of antidepressant medications. European Journal of Pharmacology, 983, 176967. doi: 10.1016/j.ejphar.2024.176967.

34. Haniff, Z.R., Bocharova, M., Mantingh, T., Rucker, J. J., Velayudhan, L., Taylor, D.M., Young, A.H., Aarsland, D., Vernon, A.C., & Thuret, S. (2024). Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases. Pharmacology & Therapeutics, 258, 108641. doi: 10.1016/j.pharmthera.2024.108641.

35. Hoseyni, Z.S., Yousefi Afrashteh, M., & Morovati, Z. (2019). Meta-analysis of the effectiveness of mindfulness-based treatments for depression and anxiety (research studies in Iran from 1380 to 1395). JSSU, 26(8), 646-661. (In Persian)

36. Doi: 10.18502/ssu.v26i8.237.

37. Kelser, B.M., Teichner, E.M., Subtirelu, R.C., & Hoss, K.N. (2024). A review of proposed mechanisms for neurodegenerative disease. Frontiers in Aging Neuroscience, 16,1370580. https://doi.org/10.3389/fnagi.2024.1370580.

38. Khalili_Torghabeh, S., Salehi Fadardi, J., Sepehri Shamloo, Z., & Rasool Zadeh Tabatabaei, K. (2022). Illness Anxiety Disorder: a Systematic Review and Meta-Analysis of Studies Related to Common Therapeutic Interventions in Iran. Clin Exc,12(2),52-68. (In Persian).

39. URL: http://ce.mazums.ac.ir/article-1-736-fa.html.

40. Kiyanzad, S., Neshat Doost, H.T., Mehrabi, H.A., & Mousav, S.G. (2021). The efficacy of brief cognitive-behavioral therapy in depression, suicidal thoughts and cognitive emotion regulation in women attempting suicide. Journal of' Psychological Science. 20(106),1767-1786. doi:10.52547/JPS.20.106.1767. (In Persian)

41. Kobel, F., Erim, Y., & Morawa, E. (2021). Predictors for successful psychotherapy: Does migration status matter?. PloS One,16(9),e0257387. https://doi.org/10.1371/journal.pone.0257387.

42. Kolahkaj, B., & Zargar, F. (2015). Effect of Mindfulness-Based Stress Reduction on Anxiety, Depression and Stress in Women with Multiple Sclerosis. Nursing and Midwifery Studies, 4(4), e29655. https://doi.org/10.17795/nmsjournal29655.

43. Kormas, P., & Moutzouri, A. (2023). Current Psychological Approaches in Neurodegenerative Diseases. In: Vlamos, P., Kotsireas, I.S., Tarnanas, I. (eds) Handbook of Computational Neurodegeneration. Springer, Cham. https://doi.org/10.1007/978-3-319-75922-7_10.

44. Kraepelien, M., Schibbye, R., Månsson, K., Sundström, C., Riggare, S., Andersson, G., Lindefors, N., Svenningsson, P., & Kaldo, V. (2020). Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson's Disease: A Randomized Controlled Trial. Journal of Parkinson's Disease, 10(2),653–664. https://doi.org/10.3233/JPD-191894.

45. Krawczuk, D., Groblewska, M., Mroczko, J., Winkel, I., & Mroczko, B. (2024). The Role of α-Synuclein in Etiology of Neurodegenerative Diseases. International Journal of Molecular sciences, 25(17),9197. https://doi.org/10.3390/ijms25179197.

46. Kwok, J.Y., Choi, E.P., Wong, J.Y., Lok, K.Y., Ho, M., Fong, D.Y., Kwan, J.C., Pang, S.Y., & Auyeung, M. (2023). A randomized clinical trial of mindfulness meditation versus exercise in Parkinson's disease during social unrest. NPJ Parkinson's Disease, 9(1),7. https://doi.org/10.1038/s41531-023-00452-w. Lamptey, R.L., Chaulagain, B., Trivedi, R., Gothwal, A., Layek, B., & Singh, J. (2022). A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. International Journal of Molecular Sciences, 23(3), 1851. https://doi.org/10.3390/ijms23031851.

47. Ly, M., Karim, H.T., Becker, J.T., Lopez, O.L., Anderson, S.J., Aizenstein, H.J., Reynolds, C.F., Zmuda, M.D., & Butters, M.A. (2021). Late-life depression and increased risk of dementia: a longitudinal cohort study. Translational Psychiatry, 11(1),147. https://doi.org/10.1038/s41398-021-01269-y.

48. Mathur, S., Gawas, C., Ahmad, I.Z., Wani, M., & Tabassum, H. (2023). Neurodegenerative disorders: Assessing the impact of natural vs drug-induced treatment options. Aging Medicine (Milton (N.S.W), 6(1),82–97. https://doi.org/10.1002/agm2.12243.

49. Merzhvynska, M., Wolf, M., Krieger, T., Berger, T., Munder, T., & Watzke, B. (2024). Prognostic Risk Factors in Randomized Clinical Trials of Face-to-Face and Internet-Based Psychotherapy for Depression: A Systematic Review and Meta-Regression Analysis. JAMA Psychiatry, 81(1), 97–100. doi:10.1001/jamapsychiatry.2023.3861.

50. Miguel, C., Harrer, M., Karyotaki, E., Plessen, C. Y., Ciharova, M., Furukawa, T. A., … Cuijpers, P. (2025). Self-reports vs clinician ratings of efficacies of psychotherapies for depression: a meta-analysis of randomized trials. Epidemiology and Psychiatric Sciences, 34, e15. doi:10.1017/S2045796025000095.

51. Moonen, A.J., Mulders, A.E., Defebvre, L., Duits, A., Flinois, B., Köhler, S., Kuijf, M.L., Leterme, A.C., Servant, D., de Vugt, M., Dujardin, K., & Leentjens, A.F. (2021). Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial. Movement Disorders: Official Journal of the Movement Disorder Society, 36(11),2539–2548. https://doi.org/10.1002/mds.28533.

52. Namvar, M., Khorrami, M., Noorollahi, A., & pournemat, M. (2020). Effectiveness of Mindfulness-Based Stress Reduction (MBSR) Therapy on Anxiety and Depression Symptoms in Patients with Multiple Sclerosis (MS), Bojnurd, Iran. Psychology of Exceptional Individuals, 10(39), 179-200. (In Persian)

53. doi:10.22054/jpe.2021.45321.2037.

54. Nuraeni, A., Suryani, S., Trisyani, Y., & Sofiatin, Y. (2023). Efficacy of Cognitive Behavior Therapy in Reducing Depression among Patients with Coronary Heart Disease: An Updated Systematic Review and Meta-Analysis of RCTs. Healthcare (Basel, Switzerland), 11(7), 943. https://doi.org/10.3390/healthcare11070943.

55. Pagonabarraga, J., Álamo, C., Castellanos, M., Díaz, S., & Manzano, S. (2023). Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sciences, 13(2),318. doi: 10.3390/brainsci13020318.

56. Pang, D., & Ruch, W. (2019). Fusing character strengths and mindfulness interventions: Benefits for job satisfaction and performance. Journal of Occupational Health Psychology, 24(1), 150–162. https://doi.org/10.1037/ocp0000144.

57. Pouyanfard, S., Mohammadpour, M., ParviziFard, A.A., & Sadeghi, K. (2020). Effectiveness of mindfulness-integrated cognitive behavior therapy on anxiety, depression and hope in multiple sclerosis patients: a randomized clinical trial. Trends in Psychiatry and Psychotherapy, 42(1),55–63. https://doi.org/10.1590/2237-6089-2018-0105.

58. Rafiee, S.H., Taklavi, S., Abolghasemi, A., & Ghalyanchi Langroodi, H. (2020). Positive Group-psychotherapy in Multiple Sclerosis: The Effect on Psychological Symptoms and Quality of Life. Caspian J Neurol Sci, 6(2),100-107. DOI: 10.32598/CJNS.6.21.231.1.

59. Raiisi, F. (2022). Cognitive analysis of conceptual metaphors for depression from the perspective of clinical psychologists: A qualitative study. Journal of Fundamentals of Mental Health, 24(3), 145-151. doi: 10.22038/jfmh.2022.20582.

60. Raiisi, F., Ebrahimi, M., Ghahvehchi_Hosseini, F., Jafari, K., & Rahmati, F. (2024). Translation, Validity, and Reliability of Depression Literacy Questionnaire in Iranian Young Adults. International Journal of Preventive Medicine, 15(1),72. DOI: 10.4103/ijpvm.ijpvm_311_23.

61. Reynolds, G.O., Saint-Hilaire, M., Thomas, C.A., Barlow, D.H., & Cronin-Golomb, A. (2020). Cognitive-Behavioral Therapy for Anxiety in Parkinson's Disease. Behavior Modification, 44(4),552–579. https://doi.org/10.1177/0145445519838828.

62. Salwierz, P., Thapa, S., Taghdiri, F., Vasilevskaya, A., Anastassiadis, C., Tang-Wai, D.F., Golas, A. C., & Tartaglia, M.C. (2024). Investigating the association between a history of depression and biomarkers of Alzheimer's disease, cerebrovascular disease, and neurodegeneration in patients with dementia. GeroScience, 46(1),783–793. https://doi.org/10.1007/s11357-023-01030-x

63. Schefft, C., Heinitz, C., Guhn, A., Brakemeier, E. L., Sterzer, P., & Köhler, S. (2023). Efficacy and acceptability of third-wave psychotherapies in the treatment of depression: a network meta-analysis of controlled trials. Frontiers in Psychiatry, 14, 1189970. https://doi.org/10.3389/fpsyt.2023.1189970.

64. Sekhon, S., & Marwaha, R. (2023). Depressive Cognitive Disorders. In StatPearls. StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/32644682/.

65. Shusharina, N., Yukhnenko, D., Botman, S., Sapunov, V., Savinov, V., Kamyshov, G., Sayapin, D., & Voznyuk, I. (2023). Modern Methods of Diagnostics and Treatment of Neurodegenerative Diseases and Depression. Diagnostics(Basel,Switzerland), 13(3),573. https://doi.org/10.3390/diagnostics13030573.

66. Tröger, A., Miguel, C., Ciharova, M., de Ponti, N., Durman, G., Cuijpers, P., & Karyotaki, E. (2024). Baseline depression severity as moderator on depression outcomes in psychotherapy and pharmacotherapy. Journal of Affective Disorders, 344,86–99. https://doi.org/10.1016/j.jad.2023.10.047.

67. Werson, A. D., Meiser-Stedman, R., & Laidlaw, K. (2022). A meta-analysis of CBT efficacy for depression comparing adults and older adults. Journal of Affective Disorders, 319, 189–201. https://doi.org/10.1016/j.jad.2022.09.020.

68. Wilson, D.M., Cookson, M.R., Van Den Bosch, L., Zetterberg, H., Holtzman, D.M., & Dewachter, I. (2023). Hallmarks of neurodegenerative diseases. Cell, 186(4),693–714. https://doi.org/10.1016/j.cell.2022.12.032.

69. Zadbagher Seighalani, M., Birashk B., Hashemian K., & Mirhashemi, M. (2019). The Effectiveness of Traditional Iranian Music Therapy on Depression, Anxiety, Aggression in PMS Patients. Journal of Psychological Studies, 15(3), 55-72. (In Persian) https://doi.org/10.22051/psy.2019.27794.1998.

70. Zamiri-Miandoab, N., Hassanzade, R., & Mirghafourvand, M. (2022). The effect of cognitive behavior therapy on anxiety and depression during COVID-19 pandemic: a systematic review and meta-analysis. Annals of General Psychiatry, 21(1), 40. https://doi.org/10.1186/s12991-022-00417-y.

71. Zegarra-Valdivia, J.A., Shany-Ur, T., Rijpma, M. G., Callahan, P., Poorzand, P., Grossman, S., McEachen, B., Kramer, J.H., Miller, B.L., & Rankin, K.P. (2025). Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration. Journal of Alzheimer's Disease, 104(2),436–451. https://doi.org/10.1177/1387287725131768